Heath · Frontiers in immunology 2018 · Observational cross-sectional and longitudinal cohort study · n=32

Proximity of Cytomegalovirus-Specific CD8 + T Cells to Replicative Senescence in Human Immunodeficiency Virus-Infected Individuals.

Cited 16 times in the scientific literature.

Level 4 - case-series / case-control

Cross-sectional observational study with a very small longitudinal subset (n=2)

PubMed 29527205 · doi:10.3389/fimmu.2018.00201 · record verified 2026-08-29

What was done

The authors examined the relationship between cytomegalovirus (CMV) coinfection, immune senescence, and inflammation in middle-aged HIV-infected individuals (men who have sex with men and heterosexuals) on stable, long-term antiretroviral therapy (ART). They measured inflammatory markers (IL-6, TNF-α, CRP) and assessed telomere lengths across lymphocyte subsets (general lymphocytes, CD8+ T cells, CD57+ CD8+ T cells, CMV-specific CD57+ CD8+ T cells, and HIV-specific CD8+ T cells), including longitudinal telomere tracking over 10 years in two subjects.

What was found

Median IL-6, TNF-α, and CRP levels were significantly higher in CMV-seropositive individuals. In all 32 tested subjects (32/32), a consistent hierarchy of telomere shortening was present: general lymphocytes had the longest telomeres, followed by CD8+ T cells, CD57+ CD8+ T cells, and CMV-specific CD57+ CD8+ T cells with the shortest telomeres. HIV-specific CD8+ T cells had longer telomeres than CMV-specific CD8+ T cells across all cases, and in the two individuals evaluated over 10 years, CMV-specific CD8+ T cell telomeres eroded faster than those of HIV-specific CD8+ T cells. Specific numerical values and p-values were not reported in the abstract.

Why it matters

These findings demonstrate that CMV-specific CD8+ T cells, rather than HIV-specific cells, are closest to replicative senescence in treated HIV infection. This identifies CMV-driven exhaustive proliferation as a key candidate driver of premature immune aging and chronic systemic inflammation in people living with HIV on ART.

Limits

The sample size for telomere subset analysis was small (n=32), and longitudinal assessment was restricted to only two subjects. The total number of participants analyzed for inflammatory markers and exact statistical values (p-values, effect sizes, confidence intervals) were omitted from the abstract. Clinical morbidity outcomes were not directly evaluated.

Cited by